EMILY DAVIE: Open Payments
NPI 1053161323 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 62 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,188 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $193 |
| Lilly USA, LLC | 14 | $171 |
| Novo Nordisk Inc | 10 | $155 |
| Astellas Pharma US Inc | 3 | $91 |
| PFIZER INC. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Acella Pharmaceuticals, LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
Products named: MOUNJARO, Wegovy, Veozah, Kerendia, PAXLOVID, SPRAVATO, QULIPTA, NP Thyroid 60.
Industry payments across NE — which companies pay providers there.
